Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,788.00    -94.00 (-1.93%)
Bid:
4,780.00
Ask:
4,782.00
Spread: 2.00 (0.042%)
Market Cap: £2.23b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

AGM Voting Update

4 Sep 2023 12:51

RNS Number : 3096L
Morgan Sindall Group PLC
04 September 2023
 

Morgan Sindall Group plc

Legal Entity Identifier (LEI) number: 2138008339ULDGZRB345

 

4 September 2023

Morgan Sindall Group plc ("the Company")

 

Update on response to 2023 AGM voting outcome

 

At our Annual General Meeting ('AGM') held on 4 May 2023, resolution 3 (Approval of the Directors' Remuneration Policy) was supported by a large majority of shareholders but received less than 80% support overall.

 

In advance of the 2023 AGM, the Remuneration Committee (the 'Committee') undertook a detailed engagement with the Company's largest shareholders in relation to the remuneration proposals, and had amended the final Remuneration Policy design in response to feedback received. Following the 2023 AGM, the Committee reached out to the Company's largest shareholders to continue the dialogue and listen to their views - and in particular to understand why those who either abstained or voted against the Directors' Remuneration Policy ('the 'Policy') had done so.

 

The Committee received responses from eight investors, the majority of whom reconfirmed support for the Policy and the management team. 

 

One shareholder raised the annual bonus deferral requirement and 2nd-year phasing down of the post-employment shareholding requirement as their reason for not supporting the resolution. In both cases the Committee is comfortable that its current approach supports appropriate alignment of executive and shareholder interests. In respect of the annual bonus deferral requirement, the Committee also considers this requirement appropriate given the current shareholdings of incumbent Executive Directors. However, the Committee will reconsider both of these Policy design features as part of the next Policy review.

 

The Committee also received feedback from two shareholders that their voting had reflected the 'against' recommendation from one of the major proxy voting agencies, which itself was primarily a result of the simultaneous increases to the Policy headroom available under the annual bonus and LTIP schemes. On this matter, the Committee maintains its view that the Policy should be sufficiently flexible to last for a full triennial review period rather than needing to revert to shareholders to seek incremental changes, and reiterates its commitment to write out to major shareholders in advance of using the increased maximum opportunities under either of the variable incentives.

 

Another shareholder requested that the Committee provide a full explanation in its Remuneration Report of the rationale for the adoption of any increase to the executive directors' incentive opportunities in future years, particularly in relation to the achievement of key strategic objectives, and this feedback is consistent with the current thinking of the Committee.

 

The Committee continues to be grateful for the feedback received and the two-way engagement with major shareholders. Given overall majority support was obtained for the Policy resolution, it is not proposed to make any further changes to the approach to remuneration that was set out in the 2022 Annual Report. The Company will, however, continue to keep the Policy under review over the coming years and welcomes ongoing dialogue with shareholders and proxy advisers.

 

 

Enquiries:

Clare Sheridan, Company Secretary +44 (0) 20 7307 9200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZLFBXKLEBBF
Date   Source Headline
12th Oct 20107:00 amRNSMorgan Sindall Group awarded ?18.5m regen project
30th Sep 20103:30 pmRNSTotal Voting Rights
28th Sep 201011:56 amRNSUpdate re acquisition of contracts from Connaught
27th Sep 201010:15 amRNS?75m Yorkshire Water framework
10th Sep 20107:00 amRNSAcquisition of contracts from Connaught
9th Aug 20107:00 amRNSHalf year report for six months to 30 June 2010
6th Aug 20107:00 amRNSMorgan Sindall Group named Preferred Bidder
22nd Jul 201010:04 amRNSDirector Declaration
8th Jul 20104:39 pmRNSDirector/PDMR Shareholding
2nd Jul 20102:49 pmRNSDirector Declaration
2nd Jul 20107:00 amRNSPre-close trading update
30th Jun 20103:51 pmRNSMorgan Sindall Group acquires Powerminster Gleeson
29th Jun 20104:26 pmRNSNotice of trading update and half-year results
21st Jun 20107:00 amRNSMORGAN SINDALL GROUP PLC WINS?95.4M HEALTH PROJECT
7th Jun 20108:59 amRNSChange of Name
28th May 20102:02 pmRNSHolding(s) in Company
13th May 201012:21 pmRNSBlocklisting Interim Review
6th May 20101:41 pmRNSResult of AGM
6th May 20107:00 amRNSAGM & Interim Management Statement
30th Apr 20101:18 pmRNSTotal Voting Rights
27th Apr 20103:51 pmRNSHolding(s) in Company
27th Apr 20103:48 pmRNSHolding(s) in Company
16th Apr 20107:30 amRNSMGNS combines businesses to form new division
1st Apr 20107:00 amRNSMORGAN SINDALL AWARDED ?500 MILLION E.ON FRAMEWORK
26th Mar 201010:18 amRNSMORGAN SINDALL JV AWARDED ?80 M FRAMEWORK CONTRACT
26th Mar 20109:58 amRNSMorgan Sindall secures framework contract
24th Mar 20109:41 amRNSAnnual Information Update
19th Mar 20102:04 pmRNSAnnual Financial Report
18th Mar 20103:53 pmRNSDirector/PDMR Shareholding
17th Mar 20104:38 pmRNSHolding(s) in Company
9th Mar 20105:14 pmRNSDirector/PDMR Shareholding
5th Mar 201011:44 amRNSDirector/PDMR Shareholding
4th Mar 20103:45 pmRNSMORGAN ASHURST SECURES ?71M CONTRACTS IN HULL BSF
25th Feb 20107:00 amRNSMorgan Sindall wins ?30m contract
23rd Feb 20107:00 amRNSPreliminary results for the year ended 31 Dec 2009
17th Feb 201011:08 amRNSMorgan Sindall JV ?2bn motorway framework
11th Feb 20104:56 pmRNSHolding(s) in Company
2nd Feb 20107:00 amRNSLovell commences ?22 million development
22nd Jan 20105:02 pmRNSHolding(s) in Company
22nd Jan 201010:30 amRNSNotice of Preliminary Results
21st Jan 20109:16 amRNSMorgan Sindall led JV appointed for ?400 million
21st Jan 20109:05 amRNSHolding(s) in Company
23rd Dec 200910:22 amRNSDirector Declaration
22nd Dec 200910:32 amRNSDirector/PDMR Shareholding
21st Dec 20097:00 amRNSAppointed preferred bidder for ?417m project
17th Dec 20097:00 amRNSPre-close trading update
10th Dec 200910:27 amRNSBlocklisting Interim Review
4th Dec 20094:13 pmRNSHolding(s) in Company
3rd Dec 20099:17 amRNSTotal Voting Rights
2nd Dec 20099:09 amRNSStatement re Analyst Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.